The dawn of the recombinant DNA revolution in the 70s and 80s led to the production and engineering of recombinant monoclonal antibodies (sometimes referred to as rAbs). Early efforts in the 80s and 90s focused on the humanization and fragmentation of antibodies. Into the 21st century the appetite to engineer antibodies with a myriad of improved functionalities has continued to grow with the creation of so-called second and third generation antibodies. To date this work has largely been the preserve of the bio-pharmaceutical industry and a small number of industry-focused academic labs. This section of the Absolute Antibody resources aims to summarize some of the efforts in this ever expanding field:
- Home
- Reagents
- Overview
- Primary Antibodies
- Overview
- Anti-Allergen Antibodies
- Anti-Coronavirus Antibodies
- Anti-Virus Antibodies
- Antibodies to Epitope Tags
- DNA/RNA Research Antibodies
- Immunotherapy Research Antibodies
- Murine Bispecific Antibody Reagents
- Neuroscience Research Antibodies
- Recombinant Antibodies from Human Patients
- Recombinant Isotype Controls
- Research-Grade Biosimilars
- Tumor Marker Antigens
- VivopureX™ Antibodies for In Vivo Research
- Secondary Antibodies
- Recombinant Proteins
- Services
- Our Technology
- About Us
- Antibody Resource
- News & Events
- How to Order